INTS vs IQV · $7.7M cap vs P/E 23, rev $15.40B
Intensity Therapeutics, Inc. Common stock (INTS) versus IQVIA Holdings Inc (IQV) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
IQVIA Holdings Inc (IQV) is a diagnostics & research company listed on US.
INTS does not have a complete income-statement cache yet.
Latest reported IQV revenue for 2024-12-31 was $15.40B. Net income was $1.37B. Revenue was up 2.8% from 2023-12-31 to 2024-12-31. IQV currently screens at market cap $30.62B and trailing P/E 22.8.
INTS currently screens at market cap $7.7M. IQV currently screens at market cap $30.62B and trailing P/E 22.8.
Not investment advice. Open the INTS and IQV stock pages for the full models.
Not investment advice.